Local Bounti (LOCL) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
14 Jan, 2026Executive summary
Q3 2024 sales reached $10.2 million, up 50% year-over-year, driven by new facilities in Texas and Washington, expanded production in Georgia, and a shift to specialty products like Arugula and Spinach.
Net loss widened to $34.3 million in Q3 2024, compared to $24.3 million in Q3 2023, due to higher interest expense and increased R&D costs.
Adjusted gross margin improved to 32% in Q3, a 300 basis point sequential increase, with gross profit at $1.4 million.
Strategic shift to specialty products led to a temporary revenue shortfall and delayed positive Adjusted EBITDA to Q2 2025.
Completed transition of Montana facility to commercial production, supporting future growth and operational efficiency.
Financial highlights
Q3 2024 sales: $10.2 million (up 50% year-over-year); nine months sales: $28.1 million (up 36%).
Adjusted gross margin: 32% in Q3 2024, up from 25% in Q3 2023.
Adjusted EBITDA loss improved to $8.4 million from $9.0 million year-over-year.
Net loss for Q3 2024: $34.3 million; EPS: $(4.01) vs. $(3.02) in Q3 2023.
Cash, cash equivalents, and restricted cash totaled $6.8 million as of September 30, 2024, with an additional $6 million provided post-quarter for working capital.
Outlook and guidance
Q4 2024 revenue expected to be approximately $11 million, implying 67% year-over-year growth.
Positive Adjusted EBITDA targeted for Q2 2025, with further margin improvement anticipated from product mix optimization and operational efficiencies.
Texas facility expected to reach optimized run rate in early Q2 2025; Georgia and Washington are at full utilization.
Company expects to continue incurring losses and negative cash flows until Texas and Washington facilities reach full commercial scale.
Plans to renegotiate credit facilities, defer principal and interest payments, and seek additional capital.
Latest events from Local Bounti
- Q2 sales up 31% to $9.4M; new facilities and financing drive growth and expansion in 2024.LOCL
Q2 20241 Feb 2026 - Revenue up 38%, debt cut by $197M, and positive adjusted EBITDA targeted by Q3 2025.LOCL
Q4 202426 Dec 2025 - 13.6M shares registered for resale; no proceeds to company; CEA leader expanding amid risks.LOCL
Registration Filing16 Dec 2025 - Amendment updates auditor's consent; no changes to business or financial disclosures.LOCL
Registration Filing16 Dec 2025 - Stockholder resale of shares from recent $10M note and warrant; no direct proceeds to company.LOCL
Registration Filing16 Dec 2025 - Key votes include director elections, auditor ratification, share issuance, and equity plan expansion.LOCL
Proxy Filing2 Dec 2025 - Vote sought on major share issuance to U.S. Bounti, with Board support and dilution implications.LOCL
Proxy Filing2 Dec 2025 - Vote sought on major share issuance to U.S. Bounti, increasing its control and diluting others.LOCL
Proxy Filing2 Dec 2025 - Shareholders will vote on director elections, auditor ratification, stock conversion, and equity plan expansion.LOCL
Proxy Filing2 Dec 2025